Estée Lauder’s 4QFY13 results surprised to the upside as organic sales growth came in at +8%, driving $0.24 in EPS versus $0.21 consensus. While FY14 guidance of $2.74-2.87 (inclusive of $0.10 FX headwind) falls below the Street at $2.94, organic sales growth guidance of 6-8% is reassuring. In 4QFY13, high-end brands grew 20% versus overall sales growth of 6%. Investors have clearly been reassured by the underlying top-line trends. As we wrote yesterday, the investment community was waiting for reassurance around the company’s sales growth. Concerns regarding the implementation of SMI also needed to be addressed and, judging by the results and earnings call commentary, it seems that the company is nearing the end of the “investment” phase of the initiative and is poised to reap some rewards.


In terms of the quantitative setup, according to our macro team’s quantitative model, the stock is breaking out above its intermediate-term TREND line.





Below, we highlight the positives and negatives from 4QFY13 earnings, the FY14 guidance, and the earnings call this morning.


What we liked:  

  • EPS of $0.24 beat consensus expectations of $0.21
  • Organic sales growth of 8% came in above expectations
  • High margin luxury skincare brands growing 20%
  • Mgmt expecting to outgrow industry by at least 1%
  • Industry growth expected to be 3-4% in FY14, 4-5% thereafter
  • FY13 operating cash flow increased 9%, mgmt guiding to 14% growth in FY14
  • Performance and opportunity in emerging markets bode well for long-term growth
  • EL fundamental setup continues to be attractive with robust growth and yield


What we didn’t like:

  • Slow sales growth continuing in U.S., Southern Europe, Korea
  • FX continuing to be a significant headwind, FY14 impact difficult to estimate at this point
  • “Temporary softness” in the U.S. – remains to be seen if this is so
  • Gross margin decline in 4QFY13 – transient, according to mgmt



Rory Green

Senior Analyst


GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more

Capital Brief: 5 Things to Watch Right Now In Washington

Here's a quick look at some key issues investors should keep an eye on from Hedgeye's JT Taylor and our team of Washington Policy analysts in D.C.

read more